Oct 12 (Reuters) – Camurus AB: * CAMURUS RECEIVES APPROVAL IN CANADA FOR OCZYESA® XR, A ONCE-MONTHLY, SELF-ADMINISTERED TREATMENT FOR ACROMEGALY Source text: Further company coverage: (Gdansk Newsroom
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Oct 12 (Reuters) - TotalEnergies said on Monday it is expanding its joint venture with…
By Andrea Shalal and Rae Wee BANGKOK, Oct 12 (Reuters) - Strong investment in AI…
MUMBAI, Oct 12 (Reuters) - STOCKS: The benchmark BSE Sensex was down 0.75% at 71,931,…
By Andrea Shalal and Rae Wee BANGKOK, Oct 12 (Reuters) - Strong investment in AI…
By Kumar Tanishk Oct 12 (Reuters) - Telecom stocks in Australia and New Zealand tumbled…
Oct 12 (Reuters) - N26: * N26 APPOINTS MARC HESS AS CHIEF FINANCIAL OFFICER Source…